Other Effects of Fluvastatin Are Investigated in Patients With Metabolic Syndrome

• Status: Completed
• Trial end date: 2006-02-01
• Target enrollment: 0
• Participant gender: All

Summary

Other effects of fluvastatin are investigated in German patients with metabolic syndrome.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Novartis
• Treatments: Fluvastatin

Criteria

Inclusion Criteria:

• Written informed consent

• Male and female patients, aged between 18 and 75 years

• Metabolic syndrome according to National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII)

Exclusion Criteria:

• History of heart failure

• HIV positive

• Stroke

Other protocol defined inclusion and exclusion criteria may apply.